RHO and cancer: Furthermore, RIP-seq analysis revealed the binding by ADAR1-p110 of many transcripts involved in cancer, including major players such as β-catenin, transforming growth factor-beta (TGF-β) receptor, Raf, Rho, and nuclear factor-kappa B (NFκB) (Table 2).